Basel Medical Group Ltd (NASDAQ:BMGL – Get Free Report) was the recipient of a significant increase in short interest in October. As of October 30th, there was short interest totaling 107,869 shares, an increase of 731.6% from the October 15th total of 12,972 shares. Based on an average daily volume of 1,433,048 shares, the short-interest ratio is currently 0.1 days. Approximately 6.8% of the company’s stock are short sold.
Wall Street Analysts Forecast Growth
BMGL has been the topic of several research reports. Weiss Ratings raised shares of Basel Medical Group from a “sell (e+)” rating to a “sell (d-)” rating in a report on Wednesday, November 4th. Wall Street Zen upgraded Basel Medical Group to a “hold” rating in a report on Saturday, November 7th. One equities research analyst has rated the stock with a Sell rating. According to data from MarketBeat.com, Basel Medical Group has a consensus rating of “Sell”.
Check Out Our Latest Report on Basel Medical Group
Basel Medical Group Price Performance
NASDAQ BMGL opened at $0.57 on Friday. The firm’s fifty day simple moving average is $4.12 and its two-hundred day simple moving average is $6.26. The company has a quick ratio of 1.21, a current ratio of 1.23 and a debt-to-equity ratio of 0.75. Basel Medical Group has a 12-month low of $0.51 and a 12-month high of $17.70.
Basel Medical Group (NASDAQ:BMGL – Get Free Report) last issued its quarterly earnings data on Friday, October 30th. The company reported ($0.31) EPS for the quarter. The firm had revenue of $3.14 million during the quarter.
About Basel Medical Group
Basel Medical Group Ltd. is an investment holding company, which engages in providing orthopedic surgeries, medical care, and diagnosis services. Its services include orthopedic surgeries, medical care, rehabilitative therapy, physiotherapy, non-surgical treatments, medical diagnosis, magnetic resonance imaging, general surgery, x-ray, lump removal, sports medicine, and total hip replacement. The company was founded by Man Hing Yip on August 10, 2023 and is headquartered in Singapore.
See Also
- Five stocks we like better than Basel Medical Group
- Checkmate for AI Chips? NVIDIA’s Crisis Opens the Board
- Can NVIDIA Maintain Its Momentum Without Huang?
- Six Flags Lost $366 Million in Q3—Its Insiders Just Went Shopping
- What Went Wrong With Amprius Technologies’ Q3? Less Than You’d Think
Receive News & Ratings for Basel Medical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Basel Medical Group and related companies with MarketBeat.com's FREE daily email newsletter.
